Pharmacological strategies to selectively label and localize muscarinic receptor subtypes
- 1 February 1997
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 40 (2) , 104-116
- https://doi.org/10.1002/(sici)1098-2299(199702)40:2<104::aid-ddr2>3.0.co;2-p
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Selective inactivation of muscarinic receptor subtypesInternational Journal of Biochemistry, 1994
- Studies of the Pharmacology, Localization, and Structure of Muscarinic Acetylcholine ReceptorsaAnnals of the New York Academy of Sciences, 1993
- Selective inactivation of muscarinic M2 and M3 receptors in guinea‐pig ileum and atria in vitroBritish Journal of Pharmacology, 1993
- Muscarinic Receptors—Characterization, coupling and functionPharmacology & Therapeutics, 1993
- Nitric oxide, a novel neuronal messengerNeuron, 1992
- Affinity of muscarinic receptor antagonists for three putative muscarinic receptor binding sitesBritish Journal of Pharmacology, 1989
- Localization of a family of muscarinic receptor mRNAs in rat brainJournal of Neuroscience, 1988
- Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genesNeuron, 1988
- Toxins from the venom of the green mamba Dendroaspis angusticeps that inhibit the binding of quinuclidinyl benzilate to muscarinic acetylcholine receptorsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1988
- Identification of a Family of Muscarinic Acetylcholine Receptor GenesScience, 1987